Intracranial hypertension associated with danazol withdrawal: a case report.

Yi-Shan Wu, Shang‐Der Chen, Shang-Der Chen, Tzu-Hui Li, Jia-Shou Liu, Jiashou Liu, Min-Yu Lan, Yung-Yee Chang, Yung‐Yee Chang
Acta neurologica Taiwanica · 2007 · vol. 16(3) , pp. 173–6 · PMID:17966958 · W2098923340
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This case report describes intracranial hypertension that developed shortly after a patient abruptly stopped taking danazol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Pseudotumor cerebri (PTC) is a seldom seen entity characterized by signs and symptoms associated with the intracranial hypertension (IH) without obvious causes. Some medical disorders and exogenous agents have been implicated in the development of PTC. Danazol is a popular gonadotropin inhibitor used for the treatment of endometriosis, breast disease and hereditary angioedema. While PTC has been occasionally reported in patients receiving danazol treatment, it is barely mentioned in those who discontinued danazol therapy abruptly. Here we report a case of IH developed soon after the withdrawal of danazol.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Pseudotumor Cerebri Adult Danazol Female Humans Pseudotumor Cerebri Pseudotumor Cerebri

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:48.452140+00:00
License: CC0 · commercial use OK